annual EBITDA:
-$484.39M+$337.95M(+41.10%)Summary
- As of today (July 5, 2025), DNA annual EBITDA is -$484.39 million, with the most recent change of +$337.95 million (+41.10%) on December 31, 2024.
- During the last 3 years, DNA annual EBITDA has risen by +$1.32 billion (+73.19%).
- DNA annual EBITDA is now -354.15% below its all-time high of -$106.66 million, reached on December 31, 2019.
Performance
DNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$68.33M+$75.16M(+52.38%)Summary
- As of today (July 5, 2025), DNA quarterly EBITDA is -$68.33 million, with the most recent change of +$75.16 million (+52.38%) on March 31, 2025.
- Over the past year, DNA quarterly EBITDA has increased by +$96.80 million (+58.62%).
- DNA quarterly EBITDA is now -271.49% below its all-time high of -$18.39 million, reached on September 30, 2021.
Performance
DNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$387.59M+$96.80M(+19.98%)Summary
- As of today (July 5, 2025), DNA TTM EBITDA is -$387.59 million, with the most recent change of +$96.80 million (+19.98%) on March 31, 2025.
- Over the past year, DNA TTM EBITDA has increased by +$403.10 million (+50.98%).
- DNA TTM EBITDA is now -1418.29% below its all-time high of -$25.53 million, reached on September 30, 2020.
Performance
DNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.1% | +58.6% | +51.0% |
| 3 y3 years | +73.2% | +89.8% | +84.0% |
| 5 y5 years | -354.1% | -167.7% | -1418.3% |
DNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.7% | -94.8% | +89.4% | at high | +89.3% |
| 5 y | 5-year | -354.1% | +76.7% | -271.5% | +95.9% | -1418.3% | +89.3% |
| alltime | all time | -354.1% | +76.7% | -271.5% | +95.9% | -1418.3% | +89.3% |
DNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$68.33M(-52.4%) | -$387.59M(-20.0%) |
| Dec 2024 | -$484.39M(-41.1%) | -$143.48M(+308.9%) | -$484.39M(-23.2%) |
| Sep 2024 | - | -$35.09M(-75.1%) | -$630.84M(-17.5%) |
| Jun 2024 | - | -$140.69M(-14.8%) | -$764.88M(-3.3%) |
| Mar 2024 | - | -$165.13M(-43.0%) | -$790.69M(-3.8%) |
| Dec 2023 | -$822.34M(-60.4%) | -$289.93M(+71.4%) | -$822.34M(+24.6%) |
| Sep 2023 | - | -$169.12M(+1.6%) | -$659.95M(-42.0%) |
| Jun 2023 | - | -$166.50M(-15.4%) | -$1.14B(-29.3%) |
| Mar 2023 | - | -$196.79M(+54.3%) | -$1.61B(-22.6%) |
| Dec 2022 | -$2.08B | -$127.54M(-80.3%) | -$2.08B(-42.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$647.02M(+1.5%) | -$3.64B(+20.9%) |
| Jun 2022 | - | -$637.75M(-4.3%) | -$3.01B(+24.2%) |
| Mar 2022 | - | -$666.43M(-60.4%) | -$2.42B(+32.8%) |
| Dec 2021 | -$1.81B(+1563.8%) | -$1.68B(+9055.7%) | -$1.82B(+903.3%) |
| Sep 2021 | - | -$18.39M(-65.2%) | -$181.80M(-3.8%) |
| Jun 2021 | - | -$52.78M(-23.3%) | -$188.94M(+38.8%) |
| Mar 2021 | - | -$68.83M(+64.7%) | -$136.16M(+102.2%) |
| Dec 2020 | -$108.58M(+1.8%) | -$41.80M(+63.7%) | -$67.33M(+163.7%) |
| Sep 2020 | - | -$25.53M | -$25.53M |
| Dec 2019 | -$106.66M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual EBITDA?
- What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
What is Ginkgo Bioworks Holdings annual EBITDA?
The current annual EBITDA of DNA is -$484.39M
What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual EBITDA is -$106.66M
What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
Over the past year, DNA annual EBITDA has changed by +$337.95M (+41.10%)
What is Ginkgo Bioworks Holdings quarterly EBITDA?
The current quarterly EBITDA of DNA is -$68.33M
What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly EBITDA is -$18.39M
What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
Over the past year, DNA quarterly EBITDA has changed by +$96.80M (+58.62%)
What is Ginkgo Bioworks Holdings TTM EBITDA?
The current TTM EBITDA of DNA is -$387.59M
What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM EBITDA is -$25.53M
What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
Over the past year, DNA TTM EBITDA has changed by +$403.10M (+50.98%)